ASX - By Stock
|
RAC |
Re:
Industry news
|
|
dalts66
|
2.1K |
713K |
6 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
2.1K
|
713K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
dalts66
|
2.1K |
713K |
4 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
2.1K
|
713K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Phase 1/2 CHM CDH17 CAR-T GMP Manufacturing Complete
|
|
dalts66
|
50 |
13K |
4 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
50
|
13K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Phase 1/2 CHM CDH17 CAR-T GMP Manufacturing Complete
|
|
dalts66
|
50 |
13K |
4 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
50
|
13K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Phase 1/2 CHM CDH17 CAR-T GMP Manufacturing Complete
|
|
dalts66
|
50 |
13K |
7 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
50
|
13K
|
7
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Chimeric receives $1.5 M advance on FY24 R&D tax incentive
|
|
dalts66
|
40 |
8.9K |
7 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
40
|
8.9K
|
7
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
dalts66
|
22K |
7.6M |
22 |
11/08/24 |
11/08/24 |
ASX - By Stock
|
22K
|
7.6M
|
22
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
dalts66
|
1.1K |
311K |
6 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
1.1K
|
311K
|
6
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
dalts66
|
1.1K |
311K |
7 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
1.1K
|
311K
|
7
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
dalts66
|
832 |
331K |
12 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
832
|
331K
|
12
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
dalts66
|
1.1K |
311K |
6 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
1.1K
|
311K
|
6
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
dalts66
|
832 |
331K |
9 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
832
|
331K
|
9
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
dalts66
|
832 |
331K |
5 |
07/08/24 |
07/08/24 |
ASX - By Stock
|
832
|
331K
|
5
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
dalts66
|
1.1K |
311K |
4 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
1.1K
|
311K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
dalts66
|
832 |
331K |
6 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
832
|
331K
|
6
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Investor Presentation
|
|
dalts66
|
38 |
9.1K |
8 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
38
|
9.1K
|
8
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
dalts66
|
832 |
331K |
5 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
832
|
331K
|
5
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
dalts66
|
22K |
7.6M |
5 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
22K
|
7.6M
|
5
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
dalts66
|
213 |
60K |
4 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
213
|
60K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Ann: First patient enrolled in CHM CDH17 Phase 1/2 clinical trial
|
|
dalts66
|
36 |
9.6K |
8 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
36
|
9.6K
|
8
|
|
ASX - By Stock
|
CHM |
Re:
Ann: First patient enrolled in CHM CDH17 Phase 1/2 clinical trial
|
|
dalts66
|
36 |
9.6K |
8 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
36
|
9.6K
|
8
|
|
ASX - By Stock
|
CHM |
Re:
Ann: First patient enrolled in CHM CDH17 Phase 1/2 clinical trial
|
|
dalts66
|
36 |
9.6K |
21 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
36
|
9.6K
|
21
|
|
ASX - By Stock
|
PTX |
Re:
PTX Media related
|
|
dalts66
|
1.6K |
670K |
8 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
1.6K
|
670K
|
8
|
|
ASX - By Stock
|
PTX |
Re:
PTX Media related
|
|
dalts66
|
1.6K |
670K |
16 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
1.6K
|
670K
|
16
|
|
ASX - By Stock
|
PTX |
Re:
PTX Media related
|
|
dalts66
|
1.6K |
670K |
9 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
1.6K
|
670K
|
9
|
|
ASX - By Stock
|
RAC |
Re:
RAC - Crystal ball gazing
|
|
dalts66
|
38 |
7.9K |
3 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
38
|
7.9K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
RAC - Crystal ball gazing
|
|
dalts66
|
38 |
7.9K |
1 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
38
|
7.9K
|
1
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
dalts66
|
1.1K |
311K |
4 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
1.1K
|
311K
|
4
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
dalts66
|
1.1K |
311K |
12 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
1.1K
|
311K
|
12
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
dalts66
|
832 |
331K |
8 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
832
|
331K
|
8
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
dalts66
|
832 |
331K |
12 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
832
|
331K
|
12
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
dalts66
|
832 |
331K |
6 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
832
|
331K
|
6
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX appoints Dr Gavin Shepherd as Non-Executive Director
|
|
dalts66
|
18 |
9.0K |
12 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
18
|
9.0K
|
12
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
dalts66
|
22K |
7.6M |
2 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
22K
|
7.6M
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
dalts66
|
832 |
331K |
11 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
832
|
331K
|
11
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
dalts66
|
832 |
331K |
3 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
832
|
331K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
dalts66
|
452 |
162K |
2 |
25/06/24 |
25/06/24 |
ASX - By Stock
|
452
|
162K
|
2
|
|
ASX - By Stock
|
PER |
Re:
FDA approves Sareptas Srp901 for the whole population
|
|
dalts66
|
63 |
19K |
20 |
25/06/24 |
25/06/24 |
ASX - By Stock
|
63
|
19K
|
20
|
|
ASX - By Stock
|
PER |
Re:
FDA approves Sareptas Srp901 for the whole population
|
|
dalts66
|
63 |
19K |
8 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
63
|
19K
|
8
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
dalts66
|
284 |
78K |
8 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
284
|
78K
|
8
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
dalts66
|
157 |
39K |
14 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
157
|
39K
|
14
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
dalts66
|
284 |
78K |
5 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
284
|
78K
|
5
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
dalts66
|
452 |
162K |
7 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
452
|
162K
|
7
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
dalts66
|
157 |
39K |
3 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
157
|
39K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
dalts66
|
157 |
39K |
4 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
157
|
39K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Will PER follow DXB on a similar journey ?
|
|
dalts66
|
47 |
13K |
32 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
47
|
13K
|
32
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
dalts66
|
452 |
162K |
3 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
452
|
162K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
dalts66
|
452 |
162K |
1 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
452
|
162K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
dalts66
|
157 |
39K |
12 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
157
|
39K
|
12
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Results of Meeting
|
|
dalts66
|
11 |
3.7K |
11 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
11
|
3.7K
|
11
|
|